Clinical Trial Results
Publication References
Nelson JC, Thase ME, Trivedi MH, Fava M, Han J, Van Tran Q, et al. Safety and Tolerability of Adjunctive Aripiprazole in Major Depressive Disorder: A Pooled Post Hoc Analysis (studies CN138-139 and CN138-163). Prim Care Companion J Clin Psychiatry. 2009;11(6):344-352.
Thase ME, Trivedi MH, Nelson JC, Fava M, Swanink R, Tran QV, et al. Examining the Efficacy of Adjunctive Aripiprazole in Major Depressive Disorder: A Pooled Analysis of 2 Studies. Prim Care Companion J Clin Psychiatry. 2008;10(6):440-447.
Trivedi MH, Thase ME, Fava M, Nelson CJ, Yang H, Qi Y, et al. Adjunctive aripiprazole in major depressive disorder: analysis of efficacy and safety in patients with anxious and atypical features. J Clin Psychiatry. 2008 Dec;69(12):1928-36.
Fava M, Wisniewski SR, Thase ME, Baker RA, Tran QV, Pikalov A, et al. M. Metabolic assessment of aripiprazole as adjunctive therapy in major depressive disorder: a pooled analysis of 2 studies. J Clin Psychopharmacol. 2009 Aug;29(4):362-7.
Marcus RN, McQuade RD, Carson WH, Hennicken D, Fava M, Simon JS, et al. The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study. J Clin Psychopharmacol. 2008 Apr;28(2):156-65.
Publication
Abstract
http://www.ncbi.nlm.nih.gov/pubmed/20098527?dopt=Abstract
http://www.ncbi.nlm.nih.gov/pubmed/19287552?dopt=Abstract
http://www.ncbi.nlm.nih.gov/pubmed/19192475?dopt=Abstract
http://www.ncbi.nlm.nih.gov/pubmed/19593176 ?dopt=Abstract
http://www.ncbi.nlm.nih.gov/pubmed/18344725?dopt=Abstract
Clinical Study Report Synopsis
CN138163.pdf